6 个月
Zacks.com on MSNAura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer StudyShares of Aura Biosciences AURA gained 7.9% on Sept. 12 after the company announced encouraging data from a phase II study ...
The four exoplanets orbit Barnard’s Star so closely that their years last only a few Earth days. They are probably rocky and, ...
Your home is your sanctuary. That's why one of the most important ways to increase your aura and make people instantly ...
Aura Intelligence is not just tracking workforce data, it is shaping the future of Organizational Decision Intelligence ...
BOSTON - Aura Biosciences, Inc ... The new data stems from a study evaluating the safety and efficacy of bel-sar, a Virus-like-Drug-Conjugate (VDC), in patients with NMIBC.
In the coming months, the Company will conduct a review of the feasibility study and evaluate alternatives to optimize scale, risk, and return profile of the project. Concurrently, Aura will implement ...
The researchers enrolled 72 patients who had migraine without aura. Following a 4-week run ... During the 3-month study period, those in the yoga group had significantly fewer headache days ...
In the coming months, the Company will conduct a review of the feasibility study and evaluate alternatives to optimize scale, risk, and return profile of the project. Concurrently, Aura will ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果